Prescription drug Published: RCT evidence Extensive real-world use

Oral contraceptives: dosing, timing and what to expect

Tracked because two things in this library genuinely matter to them: tirzepatide reduces their efficacy per its own label, and any gastric-emptying drug can shift their absorption. Adherence timing also matters more than for almost any other pill.

Also known as the pill, combined OC, mini-pill, Yaz, Alesse, Lo Loestrin, norethindrone

Educational research reference Prescription Medications

Quick reference. Everything you need to run Oral contraceptives — dosing, frequency, reconstitution math for the vial sizes people actually buy, and what it stacks with. For anything specific to your situation, ask the Guru.

Oral contraceptives quick start

Route: Oral
Typical dose: One tablet
Frequency: Daily, same time
Half-life: Agent-dependent; the mini-pill's timing window is famously tight.
Cycle: Per pack.

These are the numbers people actually run, drawn from the published record and from what the community has settled on over time. Educational reference, not medical advice — a starting point to work from, and one you can adjust as you learn how you respond.

How to run it

How often: Daily, same time
Cycle length: Per pack.
Half-life: Agent-dependent; the mini-pill's timing window is famously tight.
Route: Oral

Consistency matters more than perfect timing. Pick a slot in your day you will actually keep, and let DoseIQ handle the rest.

For women

This entry exists so DoseIQ can screen the rest of the protocol against it — the tirzepatide flag fires automatically when both are tracked.

What to expect

Most people tolerate Oral contraceptives well. Here is what is worth knowing going in, so nothing catches you by surprise.

Vomiting or severe GI effects (a rough GLP-1 titration week, for instance) can compromise a cycle's protection — the label's backup-method advice exists for this.

Known interactions

Interactions involving Oral contraceptives's drug class that DoseIQ screens for. Each one cites where it comes from — an FDA label section or the published record — because an interaction warning you can't trace is just noise.

Serious Tirzepatide + oral contraceptives — reduced efficacy

Tirzepatide slows gastric emptying enough to reduce oral contraceptive absorption — the label itself says so.

What to do: The label advises a barrier backup for 4 weeks after starting and after each dose increase.

Source: FDA label, tirzepatide §7.1

Serious Modafinil + hormonal contraception — reduced efficacy

Modafinil induces the enzyme that clears contraceptive hormones — the label warns effectiveness is reduced during use and for a month after stopping.

What to do: The label's advice is a non-hormonal backup method while on it and for one month after.

Source: FDA label, modafinil §7

Caution Slowed stomach emptying can shift this medication's absorption

The whole GLP-1 class — semaglutide, tirzepatide, retatrutide — delays gastric emptying, which changes how narrow-margin oral drugs (thyroid, warfarin, the pill) absorb.

What to do: Keep timing consistent, and re-check the relevant lab (TSH, INR) a few weeks after starting or increasing the dose.

Source: FDA labels, GLP-1 class §7

Worth knowing Aromatase inhibitor + estrogen — working against each other

One suppresses estrogen while the other supplies it — pharmacologically contradictory unless very deliberately prescribed.

What to do: Worth confirming both are supposed to be running at once.

Source: Mechanism; anastrozole label

DoseIQ screens your whole protocol against these rules automatically — every compound, prescription and supplement you track, cross-checked as you add them. Serious flags are always free.

Preparing it

Oral contraceptives does not need reconstituting — it comes ready to use.

Track this in DoseIQ Browse all compounds

This page is an educational research reference and is not medical advice. Dose figures reflect the published record and what the community has converged on — starting points to weigh, not instructions. Consult a qualified healthcare provider before starting any protocol.